SCHEMBL2541950

SCHEMBL2541950

CC(=O)OCCCI

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28627801 0.97
SCHEMBL3905928 0.92
SCHEMBL11408895 0.90 ALDH1A1 (0.56)
SCHEMBL22352622 0.90 ALDH1A1 (0.56)
SCHEMBL1263892 0.90 ALDH1A1 (0.56)
SCHEMBL29054777 0.90 ALDH1A1 (0.56)
SCHEMBL5833371 0.90 ALDH1A1 (0.56)
SCHEMBL410452 0.83
SCHEMBL315271 0.83 ALDH1A1 (0.74)
SCHEMBL189930 0.83 ALDH1A1 (0.74)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4322355-A Production of 1,3-difunctional compounds NATIONAL DISTILLERS & CHEMICAL CORP. (US) 1982-03-30 US claimed
US-4069232-A Manufacture of gamma-butyrolactones from 1,3-glycols and esters, halides and metadioxanes thereof NATIONAL DISTILLERS AND CHEMICAL CORPORATION (US) 1978-01-17 US claimed
US-12595281-B2 Indodicarbocyanine phosphoramidites with bathochromically shifted absorption and emission, and tunable hydrophobicity THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2026-04-07 US disclosed
EP-4229059-A1 3-SUBSTITUTED XANTHINE DERIVATIVES AS MRGPRX4 RECEPTOR MODULATORS Rheinische Friedrich-Wilhelms-Universität Bonn (DE) 2023-08-23 EP disclosed
US-20230248832-A1 Small Molecule Ligand-Drug Conjugates for Targeted Cancer Therapy UNIV EMORY (US) 2023-08-10 US disclosed
US-20230250126-A1 Indodicarbocyanine Phosphoramidites with Bathochromically Shifted Absorption and Emission, and Tunable Hydrophobicity THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY 2023-08-10 US disclosed
WO-2022079245-A1 3-SUBSTITUTED XANTHINE DERIVATIVES AS MRGPRX4 RECEPTOR MODULATORS RHEINISCHE-FRIEDRICH-WILHELMS-UNIVERSITÄT BONN (DE) 2022-04-21 WO disclosed
CN-108586298-B Preparation method of high-purity fudosteine 河南师范大学 2020-03-10 CN disclosed
US-20160310604-A1 SMALL MOLECULE LIGAND-DRUG CONJUGATES FOR TARGETED CANCER THERAPY CEDARS-SINAI MEDICAL CENTER 2016-10-27 US disclosed
US-20160310604-A1 SMALL MOLECULE LIGAND-DRUG CONJUGATES FOR TARGETED CANCER THERAPY CEDARS-SINAI MEDICAL CENTER 2016-10-27 US disclosed
EP-2097415-B1 8-ETHINYLXANTHINE DERIVATIVES AS SELECTIVE A2A RECEPTOR ANTAGONISTS UNIV BONN (DE) 2014-10-29 EP disclosed
US-5808044-A Indocarbocyanine and benzindocarbocyanine phosphoramidites PHARMACIA BIOTECH INC. (US) 1998-09-15 US disclosed
US-5776908-A Amphiphilic derivatives of piperazine MEGABIOS CORP. (US) 1998-07-07 US disclosed
US-5665879-A Amphiphilic derivatives of piperazine MEGABIOS CORPORATION (US) 1997-09-09 US disclosed
EP-0730568-A4 AMPHIPHILIC DERIVATIVES OF PIPERAZINE MEGABIOS CORP (US) 1997-02-19 EP disclosed
US-5556959-A Indocarbocyanine-linked phosphoramidites PHARMACIA P-L BIOCHEMICALS INC. (US) 1996-09-17 US disclosed
EP-0730568-A1 AMPHIPHILIC DERIVATIVES OF PIPERAZINE MEGABIOS CORPORATION (US) 1996-09-11 EP disclosed
WO-1995014651-A1 AMPHIPHILIC DERIVATIVES OF PIPERAZINE MEGABIOS CORPORATION (US) 1995-06-01 WO disclosed
US-4322355-A Production of 1,3-difunctional compounds NATIONAL DISTILLERS & CHEMICAL CORP. (US) 1982-03-30 US disclosed
US-4069232-A Manufacture of gamma-butyrolactones from 1,3-glycols and esters, halides and metadioxanes thereof NATIONAL DISTILLERS AND CHEMICAL CORPORATION (US) 1978-01-17 US disclosed